West Pharmaceutical Services, Inc.
WST
Kedudukan dalam Saham
#879
West Pharmaceutical Services, Inc. (WST) specializes in the development,... West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.
Harga Saham
$389.10
Disegerakkan terakhir: 2026-10-20
Modal Pasaran
$27.38B
Perubahan (1 hari)
1.30%
Perubahan (1 tahun)
39.27%
Negara
US
Perdagangan West Pharmaceutical Services, Inc. (WST)
Kategori
Healthcare
Nisbah P/E bagi West Pharmaceutical Services, Inc. (WST)
Nisbah P/E pada October 2026 TTM: 47.60
Menurut laporan kewangan dan harga saham terkini West Pharmaceutical Services, Inc., nisbah P/E semasa (TTM) ialah 47.60. Pada akhir 2023, syarikat mempunyai nisbah P/E sebanyak 44.09.
Sejarah nisbah P/E bagi West Pharmaceutical Services, Inc. dari 2000 hingga 2026
Nisbah P/E pada akhir setiap tahun
| Tahun | Nisbah P/E | Ubah |
|---|---|---|
| 2026 (TTM) | 47.60 | -1.91% |
| 2024 | 48.53 | 10.08% |
| 2023 | 44.09 | 47.53% |
| 2022 | 29.89 | -43.32% |
| 2021 | 52.73 | -12.81% |
| 2020 | 60.48 | 31.40% |
| 2019 | 46.03 | 31.45% |
| 2018 | 35.01 | -27.64% |
| 2017 | 48.39 | 11.74% |
| 2016 | 43.30 | -4.53% |
| 2015 | 45.35 | 52.71% |
| 2014 | 29.70 | -2.33% |
| 2013 | 30.41 | 31.79% |
| 2012 | 23.07 | 36.16% |
| 2011 | 16.94 | -19.35% |
| 2010 | 21.01 | 18.63% |
| 2009 | 17.71 | 24.43% |
| 2008 | 14.23 | -24.20% |
| 2007 | 18.78 | -23.63% |
| 2006 | 24.59 | 43.98% |
| 2005 | 17.08 | -55.90% |
| 2004 | 38.72 | 151.44% |
| 2003 | 15.40 | -19.63% |
| 2002 | 19.16 | -126.13% |
| 2001 | -73.33 | -133.16% |
| 2000 | 221.15 | 0.00% |
Nisbah P/E untuk syarikat serupa atau pesaing
| Syarikat | Nisbah P/E | Perbezaan Nisbah P/E | Negara |
|---|---|---|---|
| 47.48 | -0.25% |
US
|
|
| 27.43 | -42.39% |
FR
|
|
| - | - |
JP
|
|
| 56.89 | 19.51% |
US
|
|
| - | - |
CH
|
Cara membaca nisbah P/E
Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.
Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.
Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.